Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Text Messaging to Improve the Hospital-community Transition and Prevent Readmission in Patients With Cardiovascular Disease (Txt2Prevent)

NCT02336919 is registered in ClinicalTrials.gov with Simon Fraser University as lead sponsor.

NCT NCT02336919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02336919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Text Messaging to Improve the Hospital-community Transition and Prevent Readmission in Patients With Cardiovascular Disease (Txt2Prevent)
Lead sponsor
Simon Fraser University
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2015
Completion date
January 31, 2017
Enrollment
76 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome, cardiovascular disease